| Literature DB >> 25399303 |
Izabela Dobrzyńska1, Elżbieta Skrzydlewska2, Zbigniew A Figaszewski3,4.
Abstract
The aim of this study was to determine the influence of cisplatin and novel dinuclear platinum(II) complexes on the membrane electrical properties and lipid peroxidation levels of the Molt-4 human leukemia cell line. Changes in cell function may affect the basal electrical surface properties of cell membranes. These changes can be detected using electrokinetic measurements. Surface charge densities of Molt-4 cells were measured as a function of pH. A four-component equilibrium model was used to describe the interaction between the ions in solution and on cell membrane surfaces. Agreement was found between the experimental and theoretical charge variation curves of the leukemia cells at pH 2.5-9. Lipid peroxidation was estimated by measuring levels of 8-iso-prostaglandine F2α [isoprostanes]. Acid and base functional group concentrations and average association constants with hydroxyl ions were smaller in cisplatin- or dinuclear platinum(II) complex-treated leukemia cell membranes compared to those in untreated cancer cells, and the average association constants with hydrogen ions were higher. Levels of lipid peroxidation products in cisplatin- or dinuclear platinum(II) complex-treated leukemia cell were higher than those found in untreated cancer cells.Entities:
Keywords: Leukemia cells (Molt-4); Lipid peroxidation; Surface charge density
Mesh:
Substances:
Year: 2015 PMID: 25399303 PMCID: PMC4449378 DOI: 10.1007/s12013-014-0375-9
Source DB: PubMed Journal: Cell Biochem Biophys ISSN: 1085-9195 Impact factor: 2.194
Fig. 1Structure of novel platinum(II) complexes
Fig. 2Percent of MOLT-4 leukemic cell viability after 24-h incubation with cisplatin and dinuclear platinum(II) complexes
Fig. 3The membrane charge density of Molt-4 leukemia cells with and without treatment with cisplatin and Pt2(L5)4B2. The experimental values are marked by points and the theoretical ones by line
Fig. 4Effect of cisplatin and novel dinuclear platinum(II) complexes on the lipid peroxidation products measured as isoprostanes in Molt-4 leukemia cells. p < 0.05, xcompared with cancer cell, ycompared with cisplatin
Effects of cisplatin and dinuclear platinum(II) complexes on C TA, C TB, K AH, and K BOH of Molt-4 leukemia cells
| Groups | Parameters | |||
|---|---|---|---|---|
|
|
|
|
| |
| MOLT-4 | 1.90 ± 0.08 | 1.31 ± 0.06 | 18.80 ± 1.08 | 4.97 ± 0.18 |
| MOLT-4 + cisplatin | 1.58 ± 0.04a | 1.48 ± 0.05a | 22.81 ± 1.10a | 3.97 ± 0.12a |
| MOLT-4 + [Pt2(L1)4B2] | 1.43 ± 0.07a,b | 1.63 ± 0.06a,b | 32.80 ± 1.10a,b | 3.62 ± 0.19a,b |
| MOLT-4 + [Pt2(L2)4B2] | 1.45 ± 0.10a,b | 1.62 ± 0.08a,b | 35.41 ± 1.11a,b | 3.54 ± 0.12a,b |
| MOLT-4 + [Pt2(L3)4B2] | 1.48 ± 0.10a | 1.51 ± 0.09a | 28.89 ± 1.10a,b | 3.81 ± 0.11a |
| MOLT-4 + [Pt2(L4)4B2] | 1.41 ± 0.10a,b | 1.59 ± 0.10a | 30.72 ± 1.10a,b | 3.65 ± 0.11a,b |
| MOLT-4 + [Pt2(L5)4B2] | 1.37 ± 0.06a,b | 1.69 ± 0.05a,b | 32.46 ± 1.10a,b | 3.67 ± 0.10a,b |
p < 0.05
acompared with cancer cell
bcompared with cisplatin